An observational study in Spine Disease, sponsored by Universidade Nova de Lisboa. Recruiting at 1 site in Portugal. Open to participants aged 50 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-30.
Sponsored by Universidade Nova de Lisboa · Observational
Analysis of MRI advanced techniques in degenerative spinal disease.
The main questions it aims to answer are:
174 studies on the registry are indexed under Spinal Diseases; 39 are open to participants now.
This study's planned enrollment of 200 is above the median of 117 across 64 observational studies indexed under Spinal Diseases.
Browse Spinal Diseases studies →Universidade Nova de Lisboa is the lead sponsor of 43 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with suspected diagnosis of the spinal disease in study and that meet the eligibility criteria.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Healthy volunteers
Diagnostic Test: MRI advanced techniques
Patients affected by disease
Diagnostic Test: MRI advanced techniques
Participants will be submitted to MRI studies at diagnosis, during disease evolution and after treatment. Data collected will be analysed by two different neuroradiologists using advanced techniques.
ODI - Oswestry Disability Index
Measured using the ODI scale (range 0 - 50)
Time frame: 18 months
Lumbar Pain Intensity
Measured using the Numeric Pain Rating Scale (range: 0 - 10 )
Time frame: 18 months
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidade Nova de Lisboa